Post on 12-Aug-2020
Opto Circuits (India) Ltd. 1
Disclaimer
This presentation contains statements that contain “forward looking statements” including, but
without limitation, statements relating to the implementation of strategic initiatives, and other
statements relating to Opto Circuits (India) Limited and its subsidiary companies (“Opto Circuits”)
future business developments and economic performance.
While these forward looking statements indicate our assessment and future expectations
concerning the development of our business, a number of risks, uncertainties and other unknown
factors could cause actual developments and results to differ materially from our expectations.
These factors include, but are not limited to, general market, macro-economic, governmental and
regulatory trends, movements in currency exchange and interest rates, competitive pressures,
technological developments, changes in the financial conditions of third parties dealing with us,
Opto Circuits (India) Ltd. 2
technological developments, changes in the financial conditions of third parties dealing with us,
legislative developments, and other key factors that could affect our business and financial
performance.
Opto Circuits undertakes no obligation to periodically revise any forward looking statements to
reflect future / likely events or circumstances.
Section 1: Company Overview
Opto Circuits (India) Ltd. 3
A fast growing multinational medical device company
Ma
rke
t
Le
ad
er
ship
Cla
ss
Op
era
tio
ns
� World class manufacturing facilities across North America, Europe and Asia
� Investments in R&D to maintain a healthy pipeline of innovations and product developments
� Leader in cardiac and vital signs monitoring, emergency cardiac care, vascular treatmentsand sensing technologies
� USFDA listed and CE marked products which are sold in over 150 countries
� Partnerships with leading OEMs and medical institutions across the value chain
� Well-known brands include Cardiac Science, Criticare Systems, Eurocor and Mediaid
Investment HighlightsCompany Overview
Opto Circuits (India) Ltd. 4
� Revenue and PAT CAGR of more than 50% over the last 5 years with strong margins
� Conservative balance sheet with low leverage; Net Debt to Equity of 0.49x as of Sept 30, 2012
� FY2012 ROCE of 20% and ROE of 34%
Str
on
g F
ina
nc
ial
Pe
rfo
rm
an
ce
Be
st-i
n-C
lass
Op
era
tio
ns
� Investments in R&D to maintain a healthy pipeline of innovations and product developments
� 6 global R&D centres with highly skilled and integrated teams
� 205 global patents across product lines as at December 31,2012
� Global sales offices and relationships with marquee distributors
Diversified product portfolio with market leadership position
Segment Breakup
Medical Equipment
H1FY2013 Revenue: 81%
Company Overview
Interventional Devices
H1FY2013 Revenue: 18%
Opto Circuits (India) Ltd. 5
o Monitoring: Cardiac Monitoring, Vital Science Monitoring, Anaesthesia Monitoring, Thermometers
o Treatment: Defibrillation Products
o Diagnostics: Vascular Diagnostic Systems
o Consumables, Accessories and Services
o Vascular: Cardiac Stents, Balloons and accessories
o Orthopedics: Hip Implants, Suction Devices, Surgical Tools Physiotherapy Products
o Urology, Gastroenterology and
Gynaecology: Catheters, Stents, Guidewires, Dilator Sets, Needles, Baskets, Injectors
Group Company BRANDSCompany Overview
Opto Circuits (India) Ltd. 6
Global Product Brands & TrademarksCompany Overview
Opto Circuits (India) Ltd. 7
Quality and cost optimization
Manufacturing FacilitiesCompany Overview
India
USA
Europe
Opto Circuits (India) Ltd. 8
o Move manufacturing lines from high cost locations to cost efficient locations in Malaysia and India
o Keep selective product lines in the US and Europe
o New Asian manufacturing bases to help cater to the fast growing markets in MENA and SEA
o Closer to the growing customer base will enable faster logistics and an efficient supply chain
Malaysia
OEM PortfolioCompany Overview
Water Traps
Fetal Pulse OximeterAgent Gas Bench
Defib Monitor
Aanesthesia Module
Opto Circuits (India) Ltd. 9
Reusable and Disposable Sensors
Digital Thermometers
Vital Signs Monitor
Responder AED Pro
MRI friendly Vital Signs Monitor
Powerheart G3 AED
ECG Board
NIBP Module
AED Pads
NIBP Cuffs
OEM PartnershipsCompany Overview
OEM
• Specialist in SPO2 and
respiratory &
anesthetic
technologies
• Customized full
service solutions
White Label
• Consumables and
accessories for group
purchase
organizations/
distributors
• Aids institutional
Branded Consumables
• Proprietary sensing
technology for SPO2
• Low cost
manufacturing base for
group companies
Opto Circuits (India) Ltd. 10
• Strengthens
relationships to
generate additional
business
bundling
Attractive dynamics of the global med-tech industry
Industry Overview
Market Size Growth Trends
Vit
al
Sig
ns
Mo
nit
or
ing
� Current: $7 bn
� 2016: +$8 bn
� Technological advances
� Ageing population
� Lack of infrastructure in emerging markets
An
es
the
sia
an
d G
as
Mo
nit
or
ing
� Growing safety awareness
Company Overview
Opto Circuits (India) Ltd. 11
An
es
the
sia
an
d G
as
Mo
nit
or
ing
� Current: $4.8 bn
� 2016: +$7.3 bn
� Growing safety awareness
� Technology enhancements
� Government regulation
Pe
rip
he
ral
Va
sc
ula
r
Dia
gn
os
tic
s
� Current: $180 mn
� 2016: $300 mn
� Peripheral Arterial Disease (PAD) awareness
� New detection technologies
Attractive dynamics of the global med-tech industry
Industry Overview
Market Size Growth Trends
Ex
ter
na
l
De
fib
ril
lati
on
� Current: $600 mn
� 2016: $842 mn
� Awareness of the incidence of sudden cardiac arrest
� Increasing government legislation promoting or requiring external defibrillator installation
� Opportunities in the emerging markets
Ca
rdia
c
Mo
nit
or
ing
De
vic
es
� Current: $635 bn
� Broadening global incidence of cardiac disease
� Increasing acceptance of remote and continuous
Company Overview
Opto Circuits (India) Ltd. 12
Ca
rdia
c
Mo
nit
or
ing
De
vic
es
� Current: $635 bn
� 2016: $754 mn
� Increasing acceptance of remote and continuous monitoring technologies
� Opportunities in the emerging markets
Co
ron
ar
y
Ste
nt
� Current: $5.4 bn
� 2016: $6.5 bn
� Dramatic rise in cardiovascular disease
� Acceptance of minimally invasive procedures
� Expansion of Cath Lab infrastructure
Dr
ug
-Elu
tin
g
Ba
llo
on
s
� Current: $0.8 bn
� 2016: $1.3 bn
� Minimally invasive alternative to bypass surgery
� Reduction in risk and cost vs. DES
� Increasing rate of ISR (In-stent Restenosis)
Section 2: Financials
Opto Circuits (India) Ltd. 13
H1FY13 FinancialsCompany Overview
P&L Synopsis
y-o-y H1 y-o-y
FY2013 FY2012 Growth % FY2013 FY2012 Growth %
Sales 607 562 8% 1322 1083 22%
Gross Profit 266 265 0% 584 510 14%
Margin % 44% 47% 44% 47%
EBITDA 162 150 8% 354 298 19%
Margin % 27% 27% 27% 27%
PAT 116 121 -4% 254 238 7%
Margin % 19% 22% 19% 22%
(Rs. Cr.)Q2
Opto Circuits (India) Ltd. 14
Balance Sheet Synopsis
Margin % 19% 22% 19% 22%
Basic EPS 4.80 5.00 -4% 10.49 9.81 7%
30th Sept 31st Mar 30th Sept 31st Mar
Net Fixed Assets 834 754 Equity 1,990 1,699
Goodwill 450 449 Total Debt 1,084 1,172
Long Term 35% 25%
Short Term 65% 75%
(Rs. Cr.)2012 2012
(Rs. Cr.)
Net Current Assets 1,557 1,378
Corporate GovernanceCompany Overview
Shareholding pattern
Note: As of December 31, 2012
Promoters28%
FIIs37%
DIIs2%
Others33%
BSE Code: 532391
NSE Code: OPTOCIRCUI
Shares O/S in Crs: 24.2
Market Cap as on Feb 28, 2013: Rs. 1,205
Opto Circuits (India) Ltd. 15
Strong and experienced management
Key Executive Designation
Vinod Ramnani Chairman and Managing Director
Thomas Dietiker Director, M&A and OEM Business
Jayesh Patel Director, Engineering
A. N. Srinatha Company Secretary
Krishna
SudheendraGroup Chief Financial Officer
Independent board of directors
Board Member Background
Dr. Anvay MulayHOD, Adult Cardiac Surgery at the DhirubhaiAmbani Hospital
Dr. Suleman
Merchant
HOD, Radiology at Lokmanya Tilak MemorialMedical College & Hospital
Dr. William
Walter O' Neill
Executive Dean, Clinical Affairs, the Universityof Miami's Miller School of Medicine
Rajkumar
RaisinghaniIndustrialist
V. Bala
SubramaniamIndependent Finance Professional
SummaryCompany Overview
o India-headquartered medical device enterprise with a global focus on markets – both, developed and emerging
o Diversified product portfolio with an emphasis on devices with consumable components and a long-term increasing demand trend
o Highly efficient global manufacturing and distribution infrastructure supported by focused top- tier management teams for both medical equipment and interventional products
o Leadership position in key product lines secured by broad IP portfolio combined with continuing investment in product development and innovation
o Focus on driving organic growth and maximizing profitability
Opto Circuits (India) Ltd. 16
o Focus on driving organic growth and maximizing profitability
#83, Electronics City
Bengaluru - 560 100
Opto Circuits (India) Ltd.
Opto Circuits (India) Ltd. 17
Bengaluru - 560 100
Karnataka, India
Phone : +91 80 28521040/ 41/ 42 | Fax : +91 80 2852 1094
Web: www.optocircuits.com
Email: ir@optoindia.com